Skip to content

Psychedelic-assisted therapy research published in 2022

Page 5 of 5: studies 81 to 84 of 84, newest first. Back to the psychedelic-assisted therapy overview

Studies

Corrigendum: A cohort-based case report: The impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression.

Frontiers in Psychiatry 2022 Shannon Dames, Pamela Kryskow, Crosbie Watler correction

Corrigendum: A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers with PTSD and DepressionError in Figure/TableIn the published article, there was an error in Figure 2 as published. The PTSD label on the legend that is imbedded in the figure was on the legend component of the figure was posted on the anxiety...

Psychedelic-Assisted Psychotherapy: A Literature Review

2022 Meredith Victoria Welch 1 citation

Psychopharmacology to treat major mental illnesses and trauma-related disorders has been around since the 1950s and peaked around the 1980s, without substantial advancement since that time.Subsequently the psychiatric understanding and treatment of mental illness radically changed over the span of those 30 years (Braslow, 2019).Despite our understanding of trauma continuing to advance, and the...

United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.

International Journal of Drug Policy 2022 Brian S. Barnett, Sloane E Parker, Jeremy Weleff 57 citations

Medicine is currently experiencing a "psychedelic renaissance", said by many to have commenced in 2006. Since then, clinical trials have consistently demonstrated promising findings for psychedelic-assisted therapies in the treatment of various mental health conditions and addictions. While most of this work has been privately funded, governmental biomedical research funding bodies in countries...

Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study.

Frontiers in Pharmacology 2022 Daniel Perkins, Broc A. Pagni, Jerome Sarris et al. 53 citations

Background: Naturalistic and placebo-controlled studies suggest ayahuasca, a potent psychedelic beverage originating from Indigenous Amazonian tradition, may improve mental health, alter personality structure, and reduce alcohol and drug intake. To better understand ayahuasca's therapeutic potential and to identify factors that influence therapeutic efficacy, we conducted a naturalistic,...